2025
Differences in patterns of outpatient epilepsy‐specific medication initiation after acute ischemic stroke in the Medicare population
Donahue M, Brooks J, Hsu J, Price M, Blacker D, Schwamm L, Newhouse J, Westover M, Haneuse S, Moura L. Differences in patterns of outpatient epilepsy‐specific medication initiation after acute ischemic stroke in the Medicare population. Epilepsia 2025 PMID: 40184019, DOI: 10.1111/epi.18396.Peer-Reviewed Original ResearchNon-Hispanic whitesOlder age groupsAcute ischemic strokeAge groupsCommunity-dwelling beneficiariesNon-Hispanic white beneficiariesUS Medicare beneficiariesCumulative incidenceYear of dischargeUS geographic regionsAdministrative claims dataUS census divisionsIschemic strokeHospitalization causeRacial/Ethnic DifferencesMedicare beneficiariesOlder adultsWhite beneficiariesBlack/African AmericanMedicare populationClaims dataHispanic beneficiariesHospital regionMedication initiationInpatient readmissions
2023
Sociodemographic Differences in COVID-19 Pandemic Experiences Among Families in the United States
LeWinn K, Trasande L, Law A, Blackwell C, Bekelman T, Arizaga J, Sullivan A, Bastain T, Breton C, Karagas M, Elliott A, Karr C, Carroll K, Dunlop A, Croen L, Margolis A, Alshawabkeh A, Cordero J, Singh A, Seroogy C, Jackson D, Wood R, Hartert T, Kim Y, Duarte C, Schweitzer J, Lester B, McEvoy C, O’Connor T, Oken E, Bornkamp N, Brown E, Porucznik C, Ferrara A, Camargo C, Zhao Q, Ganiban J, Jacobson L, Smith P, Newby K, Jacobson L, Parker C, Gershon R, Cella D, Teitelbaum S, Stroustrup A, Lampland A, Hudak M, Washburn L, Canino G, Pastyrnak S, Neal C, Carter B, Helderman J, Simhan H, Kerver J, Barone C, Paneth N, Elliott M, Schantz S, Silver R, Wright R, Bosquet-Enlow M, Mason A, Tylavsky F, Zhao Q, Sathyanarayana S, Fussman C, Farzan S, Habre R, Tepper R, Gern J, Miller R, Nguyen R, Aschner J, Merhar S, Moore P, Pryhuber G, Smith L, Barrett E, Reynolds A, Gatzke-Kopp L, Swingler M, Mansbach J, Spergel J, Zoratti E, Bendixsen C, Bacharier L, O’Connor G, Kattan M, Rivera-Spoljaric K, Johnson C, Hertz-Picciotto I, Koinis Mitchell D, D’Sa V, Dabelea D, Deoni S, Hipwell A, Leve L, Weiss S, Lyall K, Volk H, Dager S, Schultz R, Obeid R, Rollins C, Msall M, O'Shea M, Vaidya R, Meeker J, Laham F, Wu S, Celedón J, Puls H, Teach S, Porter S, Waynik I, Iyer S, Samuels-Kalow M, Thompson A, Stevenson M, Bauer C, Inhofe N, Boos M, Macias C, Monk C, Posner J, Hershey G, Keenan K, Neiderhiser J, Litonjua A, Zeiger R, Bacharier L, Landa R, Ozonoff S, Schmidt R, Piven J, Bear K, Lenski M, Singh R, Frazier J, Gogcu S, Montgomery A, Kuban K, Douglass L, Jara H, Joseph R, Ruden D, Herbstman J, Woodruff T, Giardino A, Stanford J, Innocenti M, Conradt E, Huddleston K, Swan S. Sociodemographic Differences in COVID-19 Pandemic Experiences Among Families in the United States. JAMA Network Open 2023, 6: e2330495. PMID: 37610749, PMCID: PMC10448300, DOI: 10.1001/jamanetworkopen.2023.30495.Peer-Reviewed Original ResearchConceptsChild health outcomesCaregiver education levelLow socioeconomic statusPopulation-based studyChild's life stageCross-sectional analysisHigh school educationIndividual-level dataPandemic-related experiencesLogistic regression modelsRural caregiversCOVID-19 surveyUrban caregiversUS census divisionsHealth outcomesCOVID-19 pandemic experiencePublic health crisisHealth careSociodemographic differencesSocioeconomic statusMain OutcomesCaregiversYoung childrenUS populationEducation level
2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
Hawley J, Sun T, Chism D, Duma N, Fu J, Gatson N, Mishra S, Nguyen R, Reid S, Serrano O, Singh S, Venepalli N, Bakouny Z, Bashir B, Bilen M, Caimi P, Choueiri T, Dawsey S, Fecher L, Flora D, Friese C, Glover M, Gonzalez C, Goyal S, Halfdanarson T, Hershman D, Khan H, Labaki C, Lewis M, McKay R, Messing I, Pennell N, Puc M, Ravindranathan D, Rhodes T, Rivera A, Roller J, Schwartz G, Shah S, Shaya J, Streckfuss M, Thompson M, Wulff-Burchfield E, Xie Z, Yu P, Warner J, Shah D, French B, Hwang C, Halmos B, Verma A, Gartrell B, Goel S, Ohri N, Sica R, Thakkar A, Stockerl-Goldstein K, Butt O, Campian J, Fiala M, Henderson J, Monahan R, Zhou A, Thompson M, Bohachek P, Mundt D, Streckfuss M, Tadesse E, Lammers P, Panagiotou O, Egan P, Farmakiotis D, Khan H, Olszewski A, Loaiza-Bonilla A, Del Prete S, Bar M, Gulati A, Steve Lo K, Rose S, Stratton J, Weinstein P, Caimi P, Barnholtz-Sloan J, Garcia J, Nakayama J, Gupta S, Pennell N, Ahluwalia M, Dawsey S, Lemmon C, Nizam A, Hoppenot C, Li A, Choueiri T, Bakouny Z, Bouchard G, Busser F, Connors J, Curran C, Demetri G, Giordano A, Kelleher K, Nohria A, Schmidt A, Shaw G, Van Allen E, Nuzzo P, Xu V, Zon R, Zhang T, Halabi S, Leighton J, Lyman G, Graber J, Grivas P, Khaki A, Loggers E, Lynch R, Nakasone E, Schweizer M, Tachiki L, Vinayak S, Wagner M, Yeh A, Gatson N, Goyal S, Huynh-Le M, Rosenstein L, Yu P, Clement J, Daher A, Dailey M, Elias R, Jayaraj A, Hsu E, Menendez A, Rathmann J, Serrano O, Hwang C, Gadgeel S, Singh S, Hawley J, Hershman D, Accordino M, Bhutani D, Schwartz G, Reuben D, Alexander M, Mushtaq S, Bernicker E, Deeken J, Shafer D, Lewis M, Rhodes T, Gill D, Low C, Mashru S, Mansoor A, Zaren H, Smith S, Nagaraj G, Akhtari M, Lau E, Reeves M, Berg S, Elms D, Morgans A, Wehbe F, Altman J, Gurley M, Mulcahy M, Durbin E, Kulkarni A, Nelson H, Sachs Z, Shah S, Rosovsky R, Reynolds K, Bardia A, Boland G, Gainor J, Zubiri L, Halfdanarson T, Bekaii-Saab T, Desai A, Xie Z, Mesa R, Bonnen M, Mahadevan D, Ramirez A, Salazar M, Shah D, Shah P, Faller B, McKay R, Ajmera A, Brouha S, Cabal A, Hsiao A, Kligerman S, Shaya J, Weissmann L, Jani C, Thomson C, Knoble J, Glace M, Rink C, Stauffer K, Zacks R, Blau S, Joshi M, Menon H, Rovito M, Griffiths E, Elshoury A, Jabbour S, Misdary C, Shah M, Bashir B, McNair C, Mahmood S, Mico V, Rivera A, Flora D, Logan B, Kloecker G, Mandapakala C, Shah S, Cabebe E, Glover M, Jha A, Schapira L, Wu J, Subbiah S, Lopes G, Revankar S, Stover D, Addison D, Chen J, Gatti-Mays M, Jhawar S, Karivedu V, Lustberg M, Palmer J, Wall S, Williams N, Wulff-Burchfield E, Kasi A, Edwin N, Smits M, Chism D, Owenby S, Doroshow D, Galsky M, Wotman M, Zhu H, Fu J, Fazio A, Sueyoshi M, Huber K, Riess J, Patel K, Rubinstein S, Wood W, Jensen C, Kumar V, Wise-Draper T, Ahmad S, Grover P, Gulati S, Kharofa J, Latif T, Marcum M, Park C, Shaikh H, Bowles D, Geiger C, Markham M, Bishnoi R, Russ A, Shah C, Acoba J, Rho Y, Feldman L, Hoskins K, Gantt G, Liu L, Khan M, Nguyen R, Pasquinelli M, Schwartz C, Venepalli N, Vikas P, Friese C, Fecher L, Mavromatis B, Bijjula R, Zaman Q, Warner J, Cheng A, Davis E, Duda S, Enriquez K, French B, Gillaspie E, Hennessy C, Hausrath D, Hsu C, Johnson D, Li X, Mishra S, Reid S, Rini B, Slosky D, Shyr Y, Solorzano C, Sun T, Tucker M, Vega-Luna K, Wang L, Kennecke H, Aboulafia D, Schroeder B, Puc M, Carducci T, Goldsmith K, Van Loon S, Topaloglu U, Alimohamed S, Rice R, Cabalona W, Pilar C, Peddi P, Rosen L, McCollough B, Bilen M, Ravindranathan D, Hafez N, Herbst R, LoRusso P, Masters T, Stratton C. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Network Open 2022, 5: e2142046. PMID: 34982158, PMCID: PMC8728628, DOI: 10.1001/jamanetworkopen.2021.42046.Peer-Reviewed Original ResearchMeSH KeywordsAgedCause of DeathCensusesCOVID-19FemaleHealth FacilitiesHumansIntensive Care UnitsMaleMiddle AgedNeoplasmsOdds RatioPandemicsRegistriesRespiration, ArtificialRetrospective StudiesRisk FactorsRural PopulationSARS-CoV-2Severity of Illness IndexSocial VulnerabilitySpatial AnalysisUnited StatesUrban PopulationConceptsCOVID-19 outcomesRural-Urban Continuum CodesCohort studyLaboratory-confirmed SARS-CoV-2 infectionMortality rateUS census divisionsRegistry-based retrospective cohort studyIntensive care unit admissionRegistry-based cohort studySARS-CoV-2 infectionPatient-level risk factorsSecondary composite outcomeCare unit admissionRetrospective cohort studyCare of patientsCensus divisionsInvasive malignant neoplasmCOVID-19Significant differencesCOVID-19 diagnosisCause deathUnit admissionCause mortalityComposite outcomePatient characteristics
2014
Trends in Use of Ezetimibe After the ENHANCE Trial, 2007 Through 2010
Ross JS, Frazee SG, Garavaglia SB, Levin R, Novshadian H, Jackevicius CA, Stettin G, Krumholz HM. Trends in Use of Ezetimibe After the ENHANCE Trial, 2007 Through 2010. JAMA Internal Medicine 2014, 174: 1486-1493. PMID: 25070672, PMCID: PMC4208827, DOI: 10.1001/jamainternmed.2014.3404.Peer-Reviewed Original ResearchConceptsLipid-lowering agentsENHANCE trialEzetimibe useEzetimibe initiationPharmacy benefit managersUse of ezetimibeProgression of atherosclerosisAdults 18 yearsHalf of adultsAtherosclerosis regression trialsPredictors of useBenefit managersEzetimibe monotherapyMonotherapy usersMedication initiationEligible adultsPrescription claimsCholesterol levelsRetrospective analysisMAIN OUTCOMEAdult beneficiariesUS census divisionsDiscontinuationRegression trialsEzetimibe
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply